Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.
Recall Number: D-0658-2020
Firm: Hikma Pharmaceuticals USA Inc.
Classification: Class II
Status: Terminated
Report Date: 20200122
Initiation Date: 20191217
Termination Date: 20210609
Reason for Recall
Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)
Product Description
Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.